54.Razaghi A.Owens L.Heimann K(December 2016)."Review of the recombinant human interferor therapeuic:Impacts of prducionplattos and glycosyla o101016bi0tcc20161002 94 10.1016962m.nih 060022 55.Coventry BJ.Ashdown ML (2012)."The 20th anniversary of interleukin-2 therapy:bimodal role w.ncbi-nlm.nih.gov/pmc/articles/PMC3421468)PMID 22904643 (hups://ww bi.nlm.nih.gov/pubm 2204643)doti0.2147cmars3979hps:doi.oe/102 Fcmar.s33979) road map"(h onmunoth rap PMID 2823 PMC531910apswmwtinnha23g 319100) 011862Fs404220 v/pubm 017-0218-5( 57.Mahoney KM.Rennert PD.Freeman G(August 2015)."Combination cancer immunother apy and new doi:10.102 6 84.PMID 262 9 (h onal Approaches Effect Systemic Respo (https:// ww.hindawi.com/ou/ 92513750201E Can (hutp://www.cancer.org/docroot/ETO/content/ETO_5_3X_Coriolous_Versicolor.asp)on 15 February 60 Restifo NP Dudley ME.Rosenbere Sa (March 2012)"Adopt the Tcell response".Nature Reviews.Immunology.12(4):269-81.PMID 22437939(https://www.ncbi.n 939).doi10. 038hr 3191(h 38%2nn3191 on.117(6 146676.PMC1878537ht s://www.ncbi-nlmnihgovpmarices C1878537刀3PM1 62.Vp 1729%2F5 ww.ncbi.nlm.nih.go o(Decembe 20131N is/Penn's omized T cell w ws ASH with stellar leukemia data"(h ..com/story/novartispenns-customized-t-cell-wows-ash-stellar-leukemia-data/203 63.C 2014)"Servier stages a ry into high-stakes car-t showdown Novartis"(http://www.fiercebiotech.com/story/servier-stages-entry-high-stakes-car-t-showdown-novarti s/2014-02 4 C)w h'e Co cancer?luno thera eutics believes its can do exactly that(hup:/www.technologyreview.co techs omncancer-cure)M Techn ogy Review "(hutp er.g 013CAR-TColls) 013.12.06p range o 67.Wilhelm M,Smetak M,Schaefer-Eckart K.Kimmel B,Birkmann J,Einsele H,Kunzmann V(February uccessful a nsion of haploidentical nc 2452854d10.i86149-5876 cbi.nlm.nih.g -45ht 5876-12-45 040331 0yea山 of the United Sto ica.110(27):10886-7.PMC3704033(https://www.ncbi.nlm.nih.gov/pmc/a 233704 30630 237847 31(h med23784781)